EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 106 filers reported holding EPIZYME INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $145,000 | -66.0% | 11,717 | -62.7% | 0.08% | -39.3% |
| Q2 2018 | $426,000 | +13.9% | 31,428 | +49.0% | 0.14% | +48.4% |
| Q1 2018 | $374,000 | +54.5% | 21,091 | +9.4% | 0.09% | +28.2% |
| Q4 2017 | $242,000 | +8.5% | 19,275 | +64.7% | 0.07% | +12.7% |
| Q3 2017 | $223,000 | +23.2% | 11,700 | -21.5% | 0.06% | -47.9% |
| Q1 2016 | $181,000 | – | 14,900 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |